Invasive Fungal Infections Clinical Trial
Official title:
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
This open label, single centre, proof of concept pilot imaging trial will evaluate technique for the diagnosis of invasive Aspergillus infection. It aims to demonstrate uptake of the gallium-siderophore tracer at sites of known proven/probable invasive aspergillus app infection. It will also assess the safety and tolerability of this technique. 10 patients within 2 weeks of proven or probable invasive fungal infection (IFI) diagnosis will be recruited to this study over a period of 12-24 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05749380 -
Pharmacokinetics and Safety of AmBisome and DKF-5122
|
Phase 1 | |
| Not yet recruiting |
NCT02527928 -
Cost-Effectiveness of Amphotericin B
|
N/A | |
| Completed |
NCT02851680 -
Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.
|
N/A | |
| Completed |
NCT03572049 -
Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole
|
Phase 2/Phase 3 | |
| Suspended |
NCT05534529 -
Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age
|
Phase 1 | |
| Completed |
NCT04024995 -
Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
|
||
| Completed |
NCT00745992 -
Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
|
||
| Completed |
NCT06413056 -
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
|
Phase 4 | |
| Recruiting |
NCT05130723 -
Pharmacokinetics of Fluconazole in Children (2-18 Years)
|
||
| Recruiting |
NCT04157465 -
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
|
N/A | |
| Completed |
NCT04122560 -
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
|
Phase 4 | |
| Completed |
NCT03262584 -
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
|
||
| Completed |
NCT02678598 -
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
|
N/A | |
| Completed |
NCT05491733 -
A Bioequivalence Study of APX001 High-load and Low-load Tablets
|
Phase 1 | |
| Not yet recruiting |
NCT06220370 -
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
|
||
| Completed |
NCT04777058 -
Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
|
||
| Recruiting |
NCT03583164 -
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options
|
Phase 2 | |
| Completed |
NCT03174457 -
Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
|
||
| Completed |
NCT00750737 -
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
|
Phase 3 | |
| Not yet recruiting |
NCT06346951 -
Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
|